Oral Nifedipine or Nifedipine Plus Sildenafil Citrate for Managing High-Risk Preterm Labor Cases

Published On: 13 Nov, 2023 11:20 AM | Updated On: 13 Nov, 2023 11:20 AM

Oral Nifedipine or Nifedipine Plus Sildenafil Citrate for Managing High-Risk Preterm Labor Cases

Preterm birth is a significant issue in developing countries, causing neonatal and infant morbidity and mortality. In southern India, the prevalence of preterm delivery is 5-8%. To prevent preterm birth, interventions are crucial. 

Tocolytic therapy can delay threatened preterm labor, allowing the patient to be transferred to a neonatal intensive care unit (NICU) or receive corticosteroids to prevent or treat respiratory issues.

A recent study assessed the effectiveness of nifedipine alone and in combination with sildenafil citrate in managing threatened preterm labor cases and evaluated maternal and perinatal outcomes. The study involved 60 subjects, 30 in each group – Group A (Nifedipine) and Group B (Sildenafil +Nifedipine). 

The results showed that combining sildenafil citrate and nifedipine was more effective in preventing preterm labor than nifedipine alone. Maternal side effects and perinatal outcomes were more favorable in the combination group.

Hence, it was inferred that the synergistic effect of sildenafil citrate and nifedipine is beneficial in managing threatened preterm labor.

Source: Sigh S, Sheela S R. Indian J Obstet Gynecol Res. 2023;10(3):313-319

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks